Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 18Gynecologic 5Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 405Glioma 261Glioblastoma 204Central Nervous System Neoplasms 92Neoplasms 87Neuroblastoma 82Astrocytoma 72Neurofibromatosis 1 55Breast Neoplasms 52Meningioma 51Lung Neoplasms 42Oligodendroglioma 39Head and Neck Neoplasms 35Medulloblastoma 33Spinal Cord Neoplasms 30Sarcoma 30Leukemia 30Paraganglioma 29Pheochromocytoma 28Lymphoma 28Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 24Neuroma, Acoustic 24Ependymoma 24Melanoma 22Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Ovarian Neoplasms 20Neoplasm Metastasis 19Lymphoma, Non-Hodgkin 19

Interventions

lentiviral minigene vaccine of COVID-19 coronavirus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Microsatellite Instability × CNS × Clear all
NCT06043232 2023-09-21

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

Huashan Hospital

Unknown
360 enrolled
CNS

Glioblastoma, Glioma, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡